Clinical Trial Update: Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hepatic arterial infusion with floxuridine and dexamethasone in combination with systemic gemcitabine and oxaliplatin for unre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma
• Peripheral Cholangiocarcinoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Floxuridine (floxuridine)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma | Phase 2 | Status: COMPLETED